“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart
Article: P17 Concurrent driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients
P17 Concurrent driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients
Reviews
There are no reviews yet.
Be the first to review “Article: P17 Concurrent driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients” Cancel reply
Reviews
There are no reviews yet.